Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
5.12
-0.17 (-3.21%)
At close: Jun 8, 2026, 4:00 PM EDT
5.16
+0.04 (0.78%)
After-hours: Jun 8, 2026, 7:44 PM EDT
Annexon Market Cap
Annexon has a market cap or net worth of $838.87 million as of June 8, 2026. Its market cap has increased by 271.16% in one year.
Market Cap
838.87M
Enterprise Value
639.28M
1-Year Change
271.16%
Ranking
Category
Stock Price
$5.12
Market Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $838.87M, an increase of 31.17%. That is a compound annual growth rate of 4.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 838.87M | 12.11% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seaport Therapeutics | 859.05M |
| Xencor | 845.96M |
| LB Pharmaceuticals | 843.09M |
| MeiraGTx Holdings | 841.82M |
| Theravance Biopharma | 839.80M |
| Arbutus Biopharma | 837.56M |
| Alpha Tau Medical | 836.83M |
| Lexicon Pharmaceuticals | 835.09M |